Zobrazeno 1 - 10
of 13
pro vyhledávání: '"James J. Logie"'
Autor:
Christopher Chaloner, James J. Logie
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 56:219-227
Background Specimen contamination that goes unnoticed can have many adverse consequences for patients including inappropriate investigations or treatment decisions based on erroneous results. Little is known about UK laboratory practices relating to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c122fa5e20324b3fe3c9eff5a100e6
https://doi.org/10.1177/0004563218812500
https://doi.org/10.1177/0004563218812500
Autor:
James J Logie, Sadaf Ali, Kathryn M Marshall, Margarete M S Heck, Brian R Walker, Patrick W F Hadoke
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e14476 (2010)
Glucocorticoid-mediated inhibition of angiogenesis is important in physiology, pathophysiology and therapy. However, the mechanisms through which glucocorticoids inhibit growth of new blood vessels have not been established. This study addresses the
Externí odkaz:
https://doaj.org/article/c99b08510d6645a3837ab9ee019660f9
Autor:
T. Ramaesh, Simon C. Riley, Rebecca M. Reynolds, Fiona C. Denison, Jane E. Norman, James J. Logie, Shareen Forbes
Publikováno v:
Clinical Endocrinology. 76:887-893
Summary Objectives Circulating concentrations of the peptide kisspeptin have been proposed as a novel biomarker for early detection of pre-eclampsia. Our aims were to assess analytical and clinical performance characteristics of a commercial kisspept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8d47970fe2b7d9026f1f8a4ea08bf11
https://doi.org/10.1111/j.1365-2265.2011.04317.x
https://doi.org/10.1111/j.1365-2265.2011.04317.x
Clinical features together with elevation of pancreatic enzymes are the key diagnostic indicators of acute pancreatitis. We report a case of a woman in her 50s who presented with abdominal distension and serum amylase raised to more than 30 times the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15273c02dbd7a3a9f0464e9000731ad6
https://europepmc.org/articles/PMC4493173/
https://europepmc.org/articles/PMC4493173/
Autor:
James J, Logie, Fiona C, Denison, Simon C, Riley, Thayalini, Ramaesh, Shareen, Forbes, Jane E, Norman, Rebecca M, Reynolds
Publikováno v:
Clinical endocrinology. 76(6)
Circulating concentrations of the peptide kisspeptin have been proposed as a novel biomarker for early detection of pre-eclampsia. Our aims were to assess analytical and clinical performance characteristics of a commercial kisspeptin assay and to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb2f1b74b447395ca599c48474c7711a
https://pubmed.ncbi.nlm.nih.gov/22168508
https://pubmed.ncbi.nlm.nih.gov/22168508
Autor:
Sadaf Ali, Brian R. Walker, Margarete M. S. Heck, Kathryn M. Marshall, James J. Logie, Patrick W. F. Hadoke
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e14476 (2010)
PLoS ONE
Logie, J J, Ali, S, Marshall, K M, Heck, M M S, Walker, B R & Hadoke, P W F 2010, ' Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration ', PLoS ONE, vol. 5, no. 12, e14476 . https://doi.org/10.1371/journal.pone.0014476
PLoS ONE
Logie, J J, Ali, S, Marshall, K M, Heck, M M S, Walker, B R & Hadoke, P W F 2010, ' Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration ', PLoS ONE, vol. 5, no. 12, e14476 . https://doi.org/10.1371/journal.pone.0014476
Background Glucocorticoid-mediated inhibition of angiogenesis is important in physiology, pathophysiology and therapy. However, the mechanisms through which glucocorticoids inhibit growth of new blood vessels have not been established. This study add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13de0548c0d4f5834389bc247ecdcc8a
http://europepmc.org/articles/PMC3013101?pdf=render
http://europepmc.org/articles/PMC3013101?pdf=render
Autor:
James J. Logie, Rebecca M. Reynolds, Robert P. Millar, T. Ramaesh, Brian R. Walker, Antonia K. Roseweir, Patrick W. F. Hadoke
Publikováno v:
Endocrinology. 151(12)
Recent studies suggest that kisspeptin (a neuropeptide central to the regulation of gonadotrophin secretion) has diverse roles in human physiology, including a putative role in implantation and placental function. Kisspeptin and its receptor are pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e30c577b832241883feb16dd43a5a2e7
https://pubmed.ncbi.nlm.nih.gov/20926586
https://pubmed.ncbi.nlm.nih.gov/20926586
Publikováno v:
Reproduction (Cambridge, England). 138(1)
Kisspeptin is a neuropeptide that was originally discovered in 1996 from a metastasis tumour suppressor gene,KISS1and was appropriately named metastin. More recently, the discovery of inactivating mutations in the receptor for kisspeptin, a G protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771bf47d0ec4f2c7038c3118036eaab0
https://pubmed.ncbi.nlm.nih.gov/19336473
https://pubmed.ncbi.nlm.nih.gov/19336473
Autor:
Daniel Fuja, James Alex Tyrrell, Rakesh K. Jain, Nyall London, Walid S. Kamoun, Emmanuelle di Tomaso, James J. Logie, Lance L. Munn
Publikováno v:
PLoS ONE, Vol 4, Iss 4, p e5123 (2009)
PLoS ONE
PLoS ONE
Background: Recent clinical trials of VEGF inhibitors have shown promise in the treatment of recurrent glioblastomas (GBM). However, the survival benefit is usually short-lived as tumors escape anti-VEGF therapies. Here we tested the hypothesis that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a3a00d135c22a6b3b8ac4066b7c31ec
http://europepmc.org/articles/PMC2662415?pdf=render
http://europepmc.org/articles/PMC2662415?pdf=render
Autor:
Anna R. Dover, James J. Logie, Patrick W. F. Hadoke, Brian R. Walker, Gary R. Small, Linsay J. Macdonald
Publikováno v:
Cellular and molecular life sciences : CMLS. 63(5)
The ability of glucocorticoids to directly alter arterial function, structure and the inflammatory response to vascular injury may contribute to their well-established link with the development of cardiovascular disease. Recent studies have emphasise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::918fb33e1110651dbae638a33e723367
https://pubmed.ncbi.nlm.nih.gov/16416027
https://pubmed.ncbi.nlm.nih.gov/16416027